News & Analysis on Clinical Trial Services & Contract Research And Development
Cangene has been awarded a five-year development and supply contract by the US Department of Health and Human Services (HHS) for 200,000 doses of heptavalent botulism antitoxin, in a deal worth up to $596m (€462m).
Major drug companies across the US are in process of reformulating their over-the-counter cold medications in time for a new law that comes in to effect later this year restricting the sale of drugs that contain pseudoephedrine.
German biopharma firm Sandoz has won a landmark first-of its-kind biosimilar drug approval in the US after a long battle with the US Food and Drug Administration (FDA). The decision could open the floodgates for generics manufacturers in this...
Outsourcing-Pharma focus: cutting the cost of clinical trials
After recent allegations in the media that poor and illiterate patients in India are being used, often unknowingly, as human guinea pigs to test new drugs for the pharma giants of the West, Outsourcing-Pharma takes a look at how cutting the cost of...
Bioxel, a company which manufactures and markets taxane active pharmaceutical ingredients (APIs) used in chemotherapeutic drugs, has turned to two contract manufacturing companies to scale up production.
Packaging pre-production specialist, Esko has launched a new programme that it claims will streamline the pharma packaging process and bring new products to market up to 40 per cent faster.
A new confocal imaging module for applications such as 3D map microfluidics analysis has been launched, which will aid all phases of microfluidics development, from understanding physical phenomena in the lab through developing novel devices.